Related Experiment Video
Updated: Aug 18, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Aspirin, a silent risk factor in urology
J P Zhu1, M B Davidsen, H H Meyhoff
1Department of Surgery A, Hillerød Hospital, Denmark.
Insights
Aspirin use may increase bleeding risks during urologic procedures like prostatectomy and biopsy. Stopping aspirin a week prior and using specific treatments can manage these aspirin-induced hemorrhagic complications.
Area of Science:
- Urology
- Pharmacology
- Hemostasis
Background:
- Aspirin is widely used for pain, inflammation, fever, and cardiovascular prophylaxis.
- Aspirin use is associated with increased operative hemorrhagic complications, particularly relevant in urology.
- Understanding aspirin's pharmacological effects on hemostasis is crucial for managing surgical risks.
Purpose of the Study:
- To review the normal hemostatic mechanism and aspirin's effect on hemostasis.
- To examine literature on aspirin-induced hemorrhagic complications in urologic procedures.
- To describe strategies for managing bleeding complications in patients on aspirin.
Main Methods:
- Literature review of aspirin's pharmacological effects on hemostasis.
- Systematic review of reported hemorrhagic complications in urologic surgery.
- Analysis of management strategies for bleeding complications.
Main Results:
- Aspirin increases bleeding and transfusion needs after prostatectomy, though large trials are lacking.
- Hemorrhagic complications are reported following prostate biopsy and extracorporeal shock wave lithotripsy.
- Cessation of aspirin one week prior to procedures is suggested.
Conclusions:
- Aspirin poses a bleeding risk in urologic procedures.
- Pre-operative aspirin cessation and specific interventions can manage bleeding.
- Further placebo-controlled trials are needed to confirm risks and optimal management.
Abstract:
Aspirin is a widely used drug for its analgetic, antiinflamatory and antipyretic effects as well as for prophylactic effect in cardiovascular diseases. However, an increased number of operative hemorrhagic complications in patients on daily aspirin have been reported, an adverse effect highly relevant in urology. In this review the normal hemostatic mechanism and the chief pharmacological effect of aspirin on hemostasis is described. The literature is reviewed for hemorrhagic complications to aspirin in urology. Few reports indicate that aspirin increases bleeding and need for transfusion following prostatectomy, but no placebo-controlled clinical trials with large patient groups have been carried out. Following prostate biopsy and extracorporeal shock wave lithotripsy aspirin-induced hemorrhagic complications have been reported. Cessation of aspirin ingestion one week prior to invasive urologic procedures and correction of bleeding complications with desmopressin, platelet concentration or fresh whole blood is described.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Drug Toxicity: Risk factors
Nursing Assessment of the Genitourinary System I: Health History
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Peptic Ulcer Disease I: Introduction

